Extended Paxlovid courses show mixed results for long COVID symptoms
Mihaela Chircă
By Tarun Sai Lomte Reviewed by Lily Ramsey, LLM Jan 8 2025 Case series suggests longer nirmatrelvir/ritonavir treatments may benefit some individuals with long COVID, highlighting the need for further research into optimal usage. Study: Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series . Image Credit: Ariya J/Shutterstock.com In a recent study published in Communications Medicine , researchers examined the impact of an extended course of oral
din zilele anterioare